Price (GBX)
690.00 -% (-)
ERGOORD 1P
Track 1 instrument
Open / Last close
- / 690.00
High / Low
695.00 / 685.00
Bid / Offer
680.00 / 700.00
Turnover
-
Special Condition: -
Trading Status: Market Close
As at 20.09.20 17:42:44 - All data delayed at least 15 minutes

Ergomed PLC instruments

Select instrument to view
Equity (1)
Code Instrument name Price Change Type Documentation
ERGOORD 1P690.00
GBX
-Equity-

Price information

What's this?
Open price
-
Previous close price / date
690.00 / 18 September 2020
Volume
44,862
Turnover
-
52 week range
280.00 / 705.00
YTD return
75.57
1 year return
139.58

Instrument information

What's this?
Market
AIM
Instrument market cap (£m)
334.04
Earnings per share
0.12
Issue date
15 July 2014
ISIN
GB00BN7ZCY67
SEDOL
BN7ZCY6
Market identifier code (MIC)
AIMX
Country of share register
GB
Market segment
ASQ1
Trading service
SETSqx
Nominated Advisers
Date Time Price CurrencyVolume Trade ValueTrade type Trade flag MIC
18.09.20 16:37:25 689.00 GBX 3,000 20,670.00 Off-Book NPFT AIMX
18.09.20 16:29:06 690.00 GBX 900 6,210.00 Off-Book OILQ AIMX
18.09.20 16:18:06 690.00 GBX 22 151.80 Off-Book - AIMX
18.09.20 16:12:30 686.00 GBX 1,000 6,860.00 Off-Book - AIMX
18.09.20 15:52:56 690.00 GBX 900 6,210.00 Off-Book - XOFF

Upcoming Events

from Ergomed PLC
Ergomed 2020 Interim Results
September 22nd 2020, 8:00:00am

Duration: 1.5 hours + Add to my Calendar

Equity Research

from Ergomed PLC
Ergomed - Diversified services offering proves resilient

According to Ergomed’s H120 trading update, the business successfully navigated the COVID-19 pandemic in H120. Underlying revenues in the PrimeVigilance segment grew 36.0% (or 62.1% including the recent acquisition), while the CRO segment, unsurprisingly, saw a modest decline as a result of ...

View report
Ergomed - AGM update: ‘Revenue growth trend’ maintained

Today Ergomed held its annual general meeting (AGM). As expected, no new financial details were provided, although the executive chairman released a statement with a general business update. Q120 trading was good with ‘solid overall growth in revenue’ and cash generation ‘remain ...

View report
Ergomed - Resilient global pharma services specialist

We are initiating coverage on specialist pharmaceutical services provider Ergomed. We believe it should prove relatively resilient during the COVID-19 crisis and has the fundamentals in place to execute its growth strategy. Ergomed announced impressive audited numbers for FY19, with revenue up 26 ...

View report
Small Cap Feast

Intention to float by Gemfields Group. No Capital Raise. Currently listed on JSE. (GML:JNB) at circa £122m. The Group's key producing assets, the Kagem emerald mine in Zambia (believed to be the world's single largest producing emerald mine) and the Montepuez ruby mine in Mozambique (one of the most ...

View report
Small Cap Feast

Interswitch, a Nigeria-based payments firm, has hired advisers to resurrect plans for a stock-market listing in London and Lagos later this year, which may value the financial technology company at $1.3 billion to $1.5 billion. Voyager AIR The Company will focus on the acquisition, leasing and manag ...

View report

Latest reports

from Ergomed PLC
Ergomed plc Annual Report 2019
link

Contacts

from Ergomed PLC
Investor relations at Consilium
atErgomed PLC
+44 (0) 20 3709 5700
ergomed@consilium-comms.com
Issuer presentations live and on demand
Watch on Spark Live